SOURCE: Progressive Care Inc

Progressive Care Inc

January 28, 2016 08:00 ET

Progressive Care: PharmCo Purchases ScriptPro Robotic Dispensing System

MIAMI, FL--(Marketwired - January 28, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces the purchase of ScriptPro's CRS 225 robotic prescription dispensing system.

After evaluating several manufacturers of pharmacy robotic systems, PharmCo, LLC has signed an agreement to purchase ScriptPro's CRS 225 robotic prescription dispensing system, which is one of the newest additions to ScriptPro's line of compact robotic machines. The CRS 225 can hold up to 225 individual medications and fill over 1000 prescriptions per day with 99.7% counting accuracy. Under the terms of the agreement, the machine will be installed in PharmCo's facility upon completion of the site expansion build-out, which is currently in the permitting phase of completion.

"We are taking a giant leap forward in modernizing our operation by purchasing ScriptPro's robotic system. This technology will essentially eliminate human errors in the prescription filling process, and drastically increase workflow efficiency. The expansion as well as the installation of the CRS 225 will greatly increase the production capacity of the pharmacy, which will quickly produce financial benefits for the Company," stated S. Parikh Mars, CEO.

About Progressive Care

Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.